Addus HomeCare Corp. (NASDAQ:ADUS) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a report released on Tuesday.

According to Zacks, “ADDUS HOMECARE is a comprehensive provider of a broad range of social and medical services in the home. The company’s services include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, the Veterans Health Administration, commercial insurers and private individuals. Addus operates its business through two divisions, home & community services and home health services. The home & community services are social, or non-medical, in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living whereas the home health services are medical in nature and include physical, occupational and speech therapy, as well as skilled nursing. “

Addus HomeCare Corp. (NASDAQ:ADUS) traded up 0.04% during midday trading on Tuesday, hitting $26.04. 37,227 shares of the stock traded hands. The stock has a 50-day moving average of $24.14 and a 200 day moving average of $20.32. The firm has a market cap of $295.84 million, a PE ratio of 32.23 and a beta of 0.33. Addus HomeCare Corp. has a 52-week low of $15.33 and a 52-week high of $38.08.

Addus HomeCare Corp. (NASDAQ:ADUS) last issued its earnings results on Monday, August 1st. The company reported $0.31 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.31. The firm had revenue of $100.90 million for the quarter, compared to analysts’ expectations of $101.41 million. Addus HomeCare Corp. had a net margin of 2.47% and a return on equity of 8.54%. The firm’s revenue was up 17.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.30 earnings per share. Equities analysts forecast that Addus HomeCare Corp. will post $1.23 EPS for the current year.

A number of hedge funds have recently added to or reduced their stakes in ADUS. Advisory Research Inc. boosted its stake in Addus HomeCare Corp. by 74.9% in the second quarter. Advisory Research Inc. now owns 350,325 shares of the company’s stock worth $6,106,000 after buying an additional 150,059 shares during the last quarter. Emerald Acquisition Ltd. bought a new stake in Addus HomeCare Corp. during the second quarter worth $688,000. Comerica Bank boosted its stake in Addus HomeCare Corp. by 49.3% in the second quarter. Comerica Bank now owns 108,442 shares of the company’s stock worth $2,228,000 after buying an additional 35,810 shares during the last quarter. BlackRock Fund Advisors boosted its stake in Addus HomeCare Corp. by 18.9% in the second quarter. BlackRock Fund Advisors now owns 193,306 shares of the company’s stock worth $3,369,000 after buying an additional 30,718 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in Addus HomeCare Corp. by 2.9% in the second quarter. Dimensional Fund Advisors LP now owns 712,165 shares of the company’s stock worth $12,413,000 after buying an additional 20,175 shares during the last quarter. 90.50% of the stock is currently owned by institutional investors.

Addus HomeCare Corp. Company Profile

Addus HomeCare Corporation is a provider of home and community-based personal care services, which are provided primarily in the home, and is focused on the dual eligible (Medicare/Medicaid) population. The Company’s services include non-medical care, such as personal care, home support services and adult day care.

5 Day Chart for NASDAQ:ADUS

Receive News & Stock Ratings for Addus HomeCare Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare Corp. and related stocks with our FREE daily email newsletter.